|Previous Section||Index||Home Page|
Dr. Kumar: To ask the Secretary of State for Health how many people in (a) the North East, (b) the Tees Valley and (c) the area corresponding as closely as possible to Middlesbrough, South and East Cleveland constituency were diagnosed with (i) gonorrhoea, (ii)hepatitis, (iii) chlamydia, (iv) epididymitis and (v)syphilis in each year since 1997. 
Mr. Byrne: The data for the number of gonorrhoea, chlamydia and syphilis diagnoses made at genito-urinary medicine (GUM) clinics are only collected at strategic health authority (SHA) level, and the relevant data for County Durham and Tees Valley SHA are available on the Health Protection Agency's website at:
There is no current surveillance system which collects data on the number of epididymitis diagnoses. However, the KC60 statistical return collects
18 Apr 2006 : Column 264W
information on the total number of complicated sexually transmitted infections (B5, C4B and C5) which includes epididymitis in males. These data are shown in table 1.
|Viral hepatitis B (HbsAg positive): first diagnosis(63)||Female||0||0||0||0||0|
|Viral hepatitis B (HbsAg positive): first diagnosis(64)||Male||0||0||0||2||1|
|(63)Number of which were acute viral hepatitis B||Female||0||0||0||0||0|
|(64)Number of which were acute viral hepatitis B||Male||0||0||0||0||0|
|Viral hepatitis C: first diagnosis||Female||5||0||2||2||3|
|Viral hepatitis C: first diagnosis||Male||5||3||6||5||5|
Anne Main: To ask the Secretary of State for Health pursuant to the Answer of 10 March 2006, Official Report, column 1830W, on sexual health, what assessment she has made of chlamydia levels in Hertfordshire and Bedfordshire Strategic Health Authority; and if she will make a statement. 
Ms Rosie Winterton: Chlamydia is the most common sexually transmitted infection in England which has no obvious symptoms and can cause infertility. We are therefore tackling this through the national chlamydia screening programme (NCSP).
The White Paper, Choosing Health: Making healthier choices easier", a copy of which is available in the Library, announced an accelerated timetable to achieve national roll out of the NCSP by 2007. We are well ahead of this target.
Mr. Amess: To ask the Secretary of State for Health who the head of the Sexual Health and Substance Misuse Directorate is; what relevant specialist qualifications he or she holds; and what his or her career has been to date. 
Caroline Flint: Following a reorganisation, the Sexual Health and Substance Misuse Directorate now forms part of the health improvement directorate (HID). Dr.Fiona Adshead, Deputy Chief Medical Officer (DCMO), is the director of the HID.
Dr. Adshead has extensive experience of effectively leading, managing and delivering both clinical services and public health programmes at director level, both as DCMO and latterly as director of public health in inner London. She has significant experience at international, national and local levels, working with key stakeholders to drive forward policy development and strengthen service delivery.
As DCMO and director of health improvement, Dr.Adshead leads on health improvement policy development and ensures effective delivery of health care programmes to improve population health in areas which include obesity, sexual health, substance misuse and smoking cessation.
Ms Rosie Winterton:
Primary care trusts (PCTs) are responsible for providing sexual health promotion services which meet local needs, and they have the
18 Apr 2006 : Column 265W
freedom and flexibility to decide how best to configure these services. The Department has provided best practice guidance, through the Recommended Standards for Sexual Health Services", and the Effective Sexual Health Promotion Toolkit" to support them in this role. Sexual health and access to genitourinary medicine clinics is included as one of the six key priorities for the national health service for 200607.
Peter Law: To ask the Secretary of State for Health what assessment her Department has made of the compatability with the Human Rights Act 1998 of the Health Bill with reference to its proposed prohibition of smoking in public places. 
On the smoke-free provision of the Bill, the question of whether taking measures of the kind provided for in this Bill to control the use of products which are lawfully on sale to persons over 16 would breach the rights in Article 8 (right to respect for private and family life) was considered. However, it was not felt that, even if such rights were engaged, there would be any breach of such rights. Any interference with such rights is justified on grounds of protection of health. This is set out in the explanatory notes published alongside the Heath Bill introduced in the House of Commons on 27 October 2005. A copy is available in the Library.
Jane Kennedy: None. The main agency through which the Government supports medical and clinical research is the medical research council (MRC). The MRC, an independent body funded by the Department of Trade and Industry via the Office of Science and Technology, is currently funding one relevant study, Group A streptococcal fimbriaenovel surface structures interacting with human tonsil.
Over 75 per. cent, of the Department's total expenditure on health research is devolved to and managed by national health service organisations.
18 Apr 2006 : Column 266W
Details of individual projects, including a number concerned with group A streptococcal diseases, are available on the national research register on the Department's website at: www.dh.gov.uk/research.
|Data year||Haemorrhagic stroke||Ischaemic stroke|
Dr. Gibson: To ask the Secretary of State for Health how many and what percentage of people suffering a stroke received a brain scan within (a) three hours, (b) 24 hours and (c) 48 hours in each year since 1997. 
|Next Section||Index||Home Page|